All Work

Vandita Jadeja

Prediction: Synopsys Will Hit $650 on This Date

Synopsys posted 42% revenue growth, raised guidance, and closed a landmark $35 billion acquisition, yet the stock sits down 34% over the past year. Something has to give, and the timeline for a potential…

Vandita Jadeja · 3 weeks ago

SanDisk Has Already Exploded. Can the Stock Double Again?

SanDisk shares have already surged nearly 2,800% in a year, yet Wall Street keeps raising its targets. The real question is whether the forces driving this run have enough left to carry the stock…

Vandita Jadeja · 3 weeks ago

The Lowest-Beta Mega-Cap Just Got a $358 Target

Apple just posted its strongest June quarter ever, yet the stock sits 6% below its 52-week high while a supply-chain dispute and fading tariff tailwinds threaten to complicate the bullish case that Wall St.…

Vandita Jadeja · 3 weeks ago

AppLovin at 52-Week Low: Buy, Sell or Hold?

AppLovin shed more than half its value in 2026 after a single earnings report triggered a collapse from a 52-week high near $746. Whether that drop reflects a broken growth story or a rare…

Vandita Jadeja · 3 weeks ago

Johnson & Johnson vs AbbVie: Safe Dividend vs Higher Yield

Two healthcare giants, two very different dividend bets: one built on six decades of unbroken raises and a fortress balance sheet, the other dangling a fatter yield while racing to outrun its own blockbuster's…

Vandita Jadeja · 3 weeks ago

Big Cash, Bigger Ambitions: POET Technologies Eyes 147% Upside

POET Technologies carries a fortress balance sheet, a landmark customer contract, and a Malaysia production ramp finally moving toward real shipments, yet lawsuits, massive dilution, and a sky-high valuation make this one of the…

Vandita Jadeja · 3 weeks ago